Quantifying risk of adverse clinical events with one set of vital signs among primary care patients with hypertension

Annals of Family Medicine

Volumn 2, Issue 3, 2004, Pages 209-217

  Tierney, William M ^a,b,c,e   Brunt, Margaret ^a,b   Kesterson, Joseph ^b   Zhou, Xiao Hua ^a,b   L'Italien, Gil ^d   Lapuerta, Pablo ^d  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b REGENSTRIEF INSTITUTE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d BRISTOL MYERS SQUIBB   (United States)

^e WISHARD MEMORIAL HOSPITAL   (United States)

Author keywords

Blood pressure; Cardiovascular risk; Hypertension; Prognosis

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NITRATE; WARFARIN;

ADULT; ARTICLE; CLINICAL FEATURE; DIAGNOSTIC VALUE; ELECTRONIC MEDICAL RECORD; FEMALE; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PRIMARY MEDICAL CARE; PROGNOSIS; RISK ASSESSMENT; STROKE; VITAL SIGN; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; GENERAL PRACTICE; HEART RATE; MIDDLE AGED; MORTALITY; PHYSIOLOGY; PREDICTION AND FORECASTING; PRIMARY HEALTH CARE; RETROSPECTIVE STUDY; RISK; URBAN POPULATION;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COHORT STUDIES; FAMILY PRACTICE; FEMALE; HEART RATE; HUMANS; HYPERTENSION; KIDNEY FAILURE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; RISK; URBAN POPULATION;

EID: 3242764674     PISSN: 15441709     EISSN: None     Source Type: Journal    
DOI: 10.1370/afm.76     Document Type: Article

References (48)

1. JNC VI Coordinating Committee. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997;157:2413-2446.
2. Psaty BM, Manolio TA, Smith NL, et al. Time trends in high blood pressure control and the use of antihypertensive medications in older adults: The Cardiovascular Health Study. Arch Intern Med. 2002;162:2325-2332.
3. Alam MG, Barri YM. Systolic blood pressure is the main etiology for poorly controlled hypertension. Am J Hypertens. 2003;16:140-143.
4. Jackson JH 4th, Bramley TJ, Chiang TH, Jhaveri V, Frech F. Determinants of uncontrolled hypertension in an African-American population. Ethn Dis. 2002;12(S3):53-57.
5. Flack JM, Casciano R, Casciano J, et al. Cardiovascular disease costs associated with uncontrolled hypertension. Manag Care Interface. 2002;15:28-36.
6. Schulte KL, Meyer-Sabeliek W. Evaluation of pharmacotherapy by indirect ambulatory blood pressure monitoring in short- and long-term studies: review of the literature. J Hypertens. 1999;8(suppl): S101-S104.
7. Morgan TO, Anderson A. Different drug classes have variable effects on blood pressure depending on the time of day. Am J Hypertens. 2003;16:46-50.
8. Winnicki M, Canali C, Accurso V, Dorigatti F, Giovinazzo P, Palatini P. Relation of 24-hour ambulatory blood pressure and short-term blood pressure variability to seasonal changed in environmental temperature in stage I hypertensive subjects: results of the Harvest Trial. Clin Exp Hypertens. 1996;18:995-1012.
9. Zakopoulos NA, Kotsis VT, Pitiriga VCh, et al. White-coat effect in normotension and hypertension. Blood Press Monit. 2002;7:271-276.
10. Celis H, Staessen JA, Thijs L, et al. Cardiovascular risk in white-coat and sustained hypertensive patients. Blood Press Monit. 2002;11:352-356.
11. Staessen JA, Thijs L, Fagard R, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension JAMA. 1999;282:539-546.
12. Psaty BM, Furberg CD, Kuller LH, et al. Traditional risk factors and subclinical disease measures as predictors of first myocardial infarction in older adults. Arch Intern Med. 1999;159:1339-1347.
13. Smulyan H, Safar ME. Systolic blood pressure revisited. J Am Collaboration Cardiol. 1997;29:1407-1413.
14. Tierney WM, McDonald CJ, Luft FC. Renal disease in hypertensive adults: effect of race and type-II diabetes mellitus. Am J Kid Disease. 1989;13:485-493.
15. Glynn RJ, Chae CU, Guralnik JM, Taylor JO, Hennekens CH. Pulse pressure and mortality in older people. Arch Intern Med. 2000;160:2765-2772.
16. Alli C, Avanzini F, Bettelli G, et al. The long-term prognostic significance of repeated blood pressure measurements in the elderly. Arch Intern Med. 1999;159:1205-1212.
17. Smith AH, Simpson OF. Discriminant function analysis of factors related to myocardial infarction in male patients on antihypertensive therapy. Br Heart J. 1976;38:1194-1199.
18. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-774.
19. Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial. Circulation. 1990;82:1616-1628.
20. Somes GW, Pahor M, Shorr RI, Cushman WC, Applegate WB. The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med. 1999;159:2004-2009.
21. Smulyan H, Safar ME. The diastolic blood pressure in systolic hypertension. Ann Intern Med. 2000;132:233-237.
22. Palatini P, Casiglia E, Julius, Pessina AC. High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med. 1999;159:585-592.
23. Disegni E, Goldbourt U, Reicher-Reiss H, et al. The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. J Clin Epidemiol. 1995;48:1197-1205.
24. Chae CU, Pfeffer MA, Glynn RJ, Mitchell GF, Taylor JO, Hennekens CH. Increased pulse pressure and risk of heart failure in the elderly. JAMA. 1999;281:634-639.
25. Blacher J, Staessen JA, Girerd X, et al. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med. 2000;160:1085-1089.
26. Chen YT, Vaccarino V, Williams CS, Butler J, Berkman LF, Krumholz HM. Risk factors for heart failure in the elderly: a prospective community-based study. Am J Med. 1999;106:605-612.
27. Parati G, Trazzi S, Ravogli A, Casadei R, Omboni S, Manda G. Methodologic problems in evaluation of cardiovascular effects of stress in humans. Hypertension. 1991;17(4 suppl):III50-III55.
28. Matthews KA, Owens JF, Allen MT, Stoney CM. Do cardiovascular responses to laboratory stress relate to ambulatory blood pressure levels? Yes, in some of the people, some of the time. Psychosom Med. 1992;54:686-697.
29. McDonald CJ, Overhage JM, Tierney WM, et al. The Regenstrief Medical Record System: a quarter century experience. Int J Med Informal. 1999;54:225-253.
30. Tierney WM, Miller ME, Hui SL, McDonald CJ. Practice randomization and clinical research: the Indiana experience. Med Care. 1991;29:JS57-JS64.
31. Tierney WM, McDonald CJ. Practice databases and their uses in clinical research. Stat Med. 1991;10:541-557.
32. Fletcher RH, Fletcher SW, Wagner EH. Clinical Epidemiology: The Essentials. Baltimore, Md: Williams & Wilkens; 1988:99.
33. Tierney WM, Carr TA, Vinicor F. Predictors of mortality in diabetes mellitus. Diabetes. 1984;33(Suppl. 1):115A.
34. Friedman C, Sideli R. Tolerating spelling errors during patient validation. Comput Biomed Research. 1992;25:486-509.
35. Slater DN. Certifying the cause of death: an audit of wording inaccuracies. J Clin Pathol. 1993;46:232-234.
36. Washko RM, Frieden TR. Tuberculosis surveillance using death certificate data, New York City, 1992. Public Health Rep. 1996;111:251-255.
37. Tierney WM, Overhage JM, Murray MD, et al. Effects of computerized guidelines for outpatient management of ischemic heart disease and heart failure. J Gen Intern Med. 1999;14(suppl):125.
38. Tierney WM, McDonald CJ, Hui SL, Martin DK. Computer predictions of abnormal test results: effects on outpatient testing. JAMA. 1988;259:1194-1198.
39. Tierney WM, Martin DK, Hui SL, McDonald CJ. Using clinical data to predict abnormal serum electrolytes and blood cell profiles. J Gen Intern Med. 1989;4:375-383.
40. Cox, DR. Regression models and life tables. J R Stat Soc. 1972;34:187-202.
41. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29-36.
42. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387.
43. Weinstein MC, Feinberg HV. Clinical Decision Analysis. Philadelphia, Pa: Saunders; 1980:118.
44. Lawless JF. Statistical Models and Methods for Lifetime Data. New York, NY: Wiley & Sons; 1982.
45. McDonald CJ, Blevins L, Glazener T, Lemmon L, Martin D, Valenza M. CARE: A real world medical knowledge base. In: IEEE - Proceedings of the Compcon Twenty-eighth IEEE Computer Society International Conference. San Francisco, Calif: IEEE Computer Society Press; 1984:187-192.
46. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;12:1373-1379.
47. Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA. 1995;274:620-625.
48. Pahor M, Psaty BM, Alderman MH, et al. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomized controlled trials. Lancet. 2000;356:1949-1954.